This program is sponsored by the Health Care and Pharmaceuticals Committee.
Pharmaceutical deals can be global in scope but local in effect, as enforcers consider differing theories and remedies. The US, Canadian, EU and UK authorities' recently announced Multilateral Working Group on Pharmaceutical Mergers will reassess antitrust principles applicable to pharma deals. Our transatlantic panel of enforcers and practitioners discuss this groundbreaking development.
Bill Batchelor - Skadden Arps Et al
Joel Bamford - Competition & Markets Authority
Paul Csiszar - European Commission
Caroline Holland - Federal Trade Commission
Desma Polydorou - Pfizer Inc.